pubmed-article:9637655 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9637655 | lifeskim:mentions | umls-concept:C0225700 | lld:lifeskim |
pubmed-article:9637655 | lifeskim:mentions | umls-concept:C0018549 | lld:lifeskim |
pubmed-article:9637655 | lifeskim:mentions | umls-concept:C1153410 | lld:lifeskim |
pubmed-article:9637655 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
pubmed-article:9637655 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:9637655 | pubmed:dateCreated | 1998-7-14 | lld:pubmed |
pubmed-article:9637655 | pubmed:abstractText | Halothane alters surfactant biosynthesis and metabolism of alveolar type II cells. In addition to synthesizing surfactant, alveolar type II cells actively transport sodium (Na) from the alveolar space to the interstitium. Na enters the cells through amiloride-sensitive Na channels or Na cotransporters and is extruded by a Na pump. The purpose of this study was to examine the effects of halothane on Na transport activities. | lld:pubmed |
pubmed-article:9637655 | pubmed:language | eng | lld:pubmed |
pubmed-article:9637655 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9637655 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:9637655 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9637655 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9637655 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9637655 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9637655 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9637655 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9637655 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9637655 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9637655 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9637655 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9637655 | pubmed:month | Jun | lld:pubmed |
pubmed-article:9637655 | pubmed:issn | 0003-3022 | lld:pubmed |
pubmed-article:9637655 | pubmed:author | pubmed-author:DesmontsJ MJM | lld:pubmed |
pubmed-article:9637655 | pubmed:author | pubmed-author:FriedlanderGG | lld:pubmed |
pubmed-article:9637655 | pubmed:author | pubmed-author:AubierMM | lld:pubmed |
pubmed-article:9637655 | pubmed:author | pubmed-author:DureuilBB | lld:pubmed |
pubmed-article:9637655 | pubmed:author | pubmed-author:ClericiCC | lld:pubmed |
pubmed-article:9637655 | pubmed:author | pubmed-author:MolliexSS | lld:pubmed |
pubmed-article:9637655 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9637655 | pubmed:volume | 88 | lld:pubmed |
pubmed-article:9637655 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9637655 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9637655 | pubmed:pagination | 1606-13 | lld:pubmed |
pubmed-article:9637655 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:meshHeading | pubmed-meshheading:9637655-... | lld:pubmed |
pubmed-article:9637655 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9637655 | pubmed:articleTitle | Halothane decreases Na,K-ATPase, and Na channel activity in alveolar type II cells. | lld:pubmed |
pubmed-article:9637655 | pubmed:affiliation | Department of Anesthesia, Pr. Auboyer, Saint-Etienne, Faculté de Médecine Bichat, Paris, France. smolliex@club-internet.fr | lld:pubmed |
pubmed-article:9637655 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9637655 | lld:pubmed |